24.9 C
Bengaluru
Friday, June 18, 2021
Home COVID-19 US FDA rejects EUA for Covaxin, recommends Biologics Licence Utility route for...

US FDA rejects EUA for Covaxin, recommends Biologics Licence Utility route for approval-India Information , Firstpost


Coronavirus Reside Information Updates: Ocugen Inc, the US companion of Bharat Biotech, in a press release on Thursday introduced it can pursue submission of BLA for Covaxin, as beneficial by FDA

Coronavirus LATEST Information Updates: In a setback to Bharat  Biotech’s COVID-19 vaccine Covaxin, the US Meals and Drug Administration has “recommended” Ocugen Inc, the US companion of the Indian vaccine maker, to go for Biologics Licence Utility (BLA) route with further knowledge, nixing hopes of Emergency Use Authorisation.

 

The day by day COVID-19 depend in India remained under the one-lakh mark for the fourth consecutive day with the nation reporting 91,702 recent circumstances, whereas the day by day positivity charge dropped to 4.49 p.c, based on the Union Well being Ministry knowledge up to date on Friday.

With the recent circumstances, the entire tally of circumstances has climbed to 2,92,74,823. The COVID-19 toll climbed to three,63,079 with 3,403 recent deaths, the info up to date at 8 am confirmed

The lively circumstances additional declined to 11,21,671 comprising 3.83 p.c of the entire infections, whereas the nationwide COVID-19 restoration charge has improved to 94.93 p.c. A web decline of 46,281 circumstances has been recorded within the COVID-19 caseload in a span of 24 hours.

Additionally, 20,44,131 exams have been carried out on Thursday taking the entire cumulative exams carried out up to now for detection of COVID-19 within the nation to 37,42,42,384.

The day by day positivity charge was recorded at 4.49 p.c . It has been lower than 10 p.c for the 18th consecutive day, the ministry stated, including the weekly positivity charge has additionally declined to five.14 p.c.

Recoveries proceed to outnumber day by day new circumstances for twenty ninth consecutive day. The quantity of people that have recuperated from the illness surged to 2,77,90,073, whereas the case fatality charge has elevated to 1.24 p.c, the info acknowledged. Cumulatively, 24,60,85,649 COVID-19 vaccine doses have been administered up to now beneath the nationwide vaccination drive.

India’s COVID-19 tally had crossed the 20-lakh mark on 7 August, 30 lakh on 23 August, 40 lakh on 5 September and 50 lakh on 16 September . It went previous 60 lakh on 28 September, 70 lakh on 11 October, crossed 80 lakh on 29 October, 90 lakh on 20 November and surpassed the one-crore mark on 19 December. India crossed the grim milestone of two crore on 4 Could.

The three,403 new fatalities embody 1,915 from Maharashtra, 358 from Tamil Nadu, 194 every from Karnataka and Kerala.

A complete of three,63,079 deaths have been reported up to now within the nation together with 1,03,748 from Maharashtra, 32,485 from Karnataka, 28,528 from Tamil Nadu, 24,748 from Delhi, 21,597 from Uttar Pradesh, 16,642 from West Bengal, 15,367 from Punjab and 13,285 from Chhattisgarh.

The ministry harassed that greater than 70 p.c of the deaths occurred because of comorbidities. “Our figures are being reconciled with the Indian Council of Medical Research,” the ministry stated on its web site, including that state-wise distribution of figures is topic to additional verification and reconciliation.



Source link

Most Popular